Skip to content

US

Americas

US - English
US - Spanish
Brazil

Europe

France
Germany
Italy
Spain
United Kingdom

Asia Pacific

Austalia

PATIENTS CONTACT

VUR in Review
Treating VUR
About Deflux
Deflux Learning Center

VUR in Review
Treating VUR
About Deflux
Deflux Learning Center

PATIENTS CONTACT

US

Americas

US - English
US - Spanish
Brazil

Europe

France
Germany
Italy
Spain
United Kingdom

Asia Pacific

Austalia

LEARNING
CENTER

Advancing vesicoureteral reflux education

Welcome to the Deflux Learning Center, your resource for valuable vesicoureteral reflux and Deflux-related information. The available tools and resources are for you, your referring physicians, administrators and caregivers.

Please see complete Prescribing Information for DEFLUX here.

For product information, adverse event reports and product complaint reports, contact:

Teleflex
Medical Information Department

T: 844-350-9656
F: 510-595-8183
E: palettemc@dlss.com

Which children are at risk for VUR? How is VUR diagnosed and graded? How likely is VUR to spontaneously resolve? What is the connection between VUR and UTIs?

Sales Representative

APM039B

VUR REVIEW

Children & VUR
Diagnosing & Grading VUR
Spontaneous Resolution
VUR & UTIs

TREATING VUR

VUR & Antibiotics
VUR & Open Surgery
Comparing Treatments
Parental Preference

ABOUT DEFLUX

How Deflux Works
Efficacy/Long-term Results
Treating with Deflux
Administering Deflux
Deflux Safety
Reimbursement

DEFLUX LEARNING CENTER

Podcast: The PedSpace
Educational Videos & Webinars
Clinical Articles
Brochures & Downloadable Tools
Upcoming Events

FOLLOW US

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

Deflux^® (hyaluronic acid/dextranomer) is contraindicated in patients with any of the following conditions: non-functional kidney(s), hutch diverticulum, ureterocele, active voiding dysfunction, and ongoing urinary tract infection.

Safety and efficacy of treatment of duplex systems, use of more than 6 mL of Deflux (3 mL at each ureteral orifice) at the same treatment session, and treatment of children under 1 year of age have not been established.

Terms of Use
Privacy Policy
Important Safety Information
Contact
Physicians

DISCLAIMER

You are now entering a site that is for U.S. healthcare professionals only. By selecting I CONFIRM below, you certify that you are a U.S. healthcare professional and wish to proceed to this section of the site. Products or treatments described on this site are available in the United States but may not be available in all other countries.

I certify that I am a licensed U.S. healthcare professional and wish to proceed to the healthcare professional section of this site.

CANCEL I CONFIRM

LEARNINGCENTER

Advancing vesicoureteral reflux education

Podcast:The Pedspace

Educational Videos& Webinars

ClinicalArticles

Brochures & Downloadable Tools

Upcoming DefluxEvents

DISCLAIMER

LEARNING
CENTER

Podcast:
The Pedspace

Educational Videos
& Webinars

Clinical
Articles

Brochures &
Downloadable Tools

Upcoming Deflux
Events